Evidence map›Paper›PMID 11238556›Full record

ArticleThe Journal of clinical investigation2001

Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs.

A Pugliese, D Brown, D Garza, D Murchison, M Zeller, M J Redondo, M Redondo, J Diez, G S Eisenbarth, D D Patel and 1 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 171 citations in OpenAlex.

  1. Trial
  2. Article
  3. Extrathymic AIRE-Expressing Cells: A Historical Perspective.Advances in experimental medicine and biology · 2024
    Article
  4. Review
  5. Article
  6. Targeting DEC-205Molecular medicine (Cambridge, Mass.) · 2018
    Article
  7. Islet-reactive CD8Science immunology · 2018
    Article
  8. Autoreactive T cells in type 1 diabetes.The Journal of clinical investigation · 2017
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Etiopathogenesis of insulin autoimmunity.Anatomy research international · 2012
    Article
4 · The record

Corrections and comments

  • Erratum issued
    Redondo, M [corrected to Redondo, MJ]
5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

A PuglieseImmunogenetics Program, Diabetes Research Institute, University of Miami School of Medicine, Miami, Florida, USA. apuglies@med.miami.edu
D Brown
D Garza
D Murchison
M Zeller
M J Redondo
M Redondo
J Diez
G S Eisenbarth
D D Patel
C Ricordi
University of Miami · USUniversity of Colorado Denver · USDuke University · US

Funding

ANALYSIS OF THE THYMIC MICROENVIRONMENT IN SCIDR01AI047604 · NIAID · DUKE UNIVERSITY · PI PATEL, DHAVALKUMAR D. · 1999 to 2002
$517k
PROINSULIN EXPRESSION IN THE IMMUNE SYSTEMR01AI044456 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PUGLIESE, ALBERTO · 1998 to 2000
$193k
NIAID NIH HHS AI-44456NIAID NIH HHS AI-47604
6 · The paper itself

Abstract

Recent reports indicate that genes with tissue-restricted expression, including those encoding the type 1 diabetes autoantigens insulin, glutamic acid decarboxylase (GAD), and the tyrosine-phosphatase-like protein IA-2 (or ICA512), are transcribed in the thymus. The reported modulation of diabetes susceptibility by genetically determined differences in thymic insulin levels and studies in transgenic mice provide correlative and functional evidence that thymic expression of peripheral proteins is crucial for immunological self-tolerance. However, there are no specific data about the existence, tissue distribution, phenotype, and function of those cells that express insulin and other self-antigens in the human thymus. We find that the human thymus harbors specialized cells synthesizing (pro)insulin, GAD, and IA-2, mainly localized in the medulla, and we demonstrate such cells also in peripheral lymphoid organs (spleen and lymph nodes). Phenotypic analysis qualifies these cells as antigen-presenting cells (APCs), including both dendritic cells and macrophages. These cells often appear surrounded by apoptotic lymphocytes, both in thymus and spleen, and may therefore be involved in the deletion of autoreactive lymphocytes. Our findings demonstrate the existence of, and define the tissue distribution and phenotype of, a novel subset of APCs expressing self-antigens in human lymphoid organs that appear to be involved in the regulation of self-tolerance throughout life.

Indexed as

Self ToleranceAdolescentAdultAgedAntigen-Presenting CellsApoptosisAutoantigensClonal DeletionDiabetes Mellitus, Type 1FemaleGene ExpressionGlutamate DecarboxylaseHumansInfantInfant, NewbornLymph NodesAutoantigensGlutamate DecarboxylaseMembrane ProteinsProinsulinProtein Tyrosine Phosphatase, Non-Receptor Type 1Protein Tyrosine PhosphatasesPTPRN protein, humanReceptor-Like Protein Tyrosine Phosphatases, Class 8

Identifiers

PMID11238556
PMCPMC199421
OpenAlexW2144177716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.